Volume 67, Issue 2, Pages (February 2005)

Slides:



Advertisements
Similar presentations
Acid-base profile in patients on PD
Advertisements

Hemodialyzer: From macro-design to membrane nanostructure; the case of the FX- class of hemodialyzers  Claudio Ronco, Sudhir Kumar Bowry, Alessandra Brendolan,
Downloadable computer models for renal replacement therapy
Acid-base profile in patients on PD
Plasma Clearance.
Volume 66, Issue 4, Pages (October 2004)
Elaine M. Spalding, Paul W. Chamney, Ken Farrington 
Alex Castellarnau, Michael Werner, Roman Günthner, Marten Jakob 
Determinants of phosphorus mobilization during hemodialysis
Volume 54, Issue 3, Pages (September 1998)
Clinical Practice Guidelines for Hemodialysis Adequacy, Update 2006
Volume 85, Issue 6, Pages (June 2014)
Volume 55, Issue 2, Pages (February 1999)
Solute-Solver: A Web-Based Tool for Modeling Urea Kinetics for a Broad Range of Hemodialysis Schedules in Multiple Patients  John T. Daugirdas, MD, Thomas.
Volume 57, Issue 6, Pages (June 2000)
Pejman Mohammadi, Niko Beerenwinkel, Yaakov Benenson  Cell Systems 
Volume 54, Issue 2, Pages (August 1998)
Volume 59, Issue 1, Pages (January 2001)
Volume 63, Issue 4, Pages (April 2003)
Volume 66, Pages S3-S24 (July 2004)
Volume 77, Issue 8, Pages (April 2010)
Effects of a reduced inner diameter of hollow fibers in hemodialyzers
Volume 67, Issue 4, Pages (April 2005)
Volume 56, Issue 2, Pages (August 1999)
How to interpret the eGFR in patients with small body surface area
The online measurement of hemodialysis dose (Kt): Clinical outcome as a function of body surface area  Edmund G. Lowrie, Zhensheng Li, Norma Ofsthun,
Volume 67, Issue 1, Pages (January 2005)
Multicompartment urea kinetics in well-dialyzed children
Volume 58, Issue 5, Pages (November 2000)
Volume 73, Pages S5-S17 (April 2008)
Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure  A. Parikova, W. Smit, D.G. Struijk,
Volume 66, Issue 3, Pages (September 2004)
Blood pressure targets in hemodialysis patients
Volume 61, Issue 6, Pages (June 2002)
Peritoneal dialysis adequacy and risk of death
Effects of a reduced inner diameter of hollow fibers in hemodialyzers
Volume 65, Issue 5, Pages (May 2004)
A method for monitoring vascular access function during hemodialysis
Martin K. Kuhlmann, Martina Heckmann, Werner Riegel, Hans Köhler 
Evaluation and prediction of urea rebound and equilibrated Kt/V in the pediatric hemodialysis population  Stuart L. Goldstein, MD, Jonathan M. Sorof,
Volume 69, Issue 3, Pages (February 2006)
Volume 67, Issue 6, Pages (June 2005)
Angiotensin II production and distribution in the kidney – II
Volume 71, Issue 6, Pages (March 2007)
On-line mixed hemodiafiltration with a feedback for ultrafiltration control: Effect on middle-molecule removal  Luciano A. Pedrini, Vincenzo De Cristofaro 
The role of daily dialysis in the control of hyperphosphatemia
Volume 61, Issue 1, Pages (January 2002)
Volume 64, Issue 3, Pages (September 2003)
Guillaume Jean, Bernard Charra, Charles Chazot, Guy Laurent 
Volume 68, Issue 4, Pages (October 2005)
Michael W. Steffes, Derek Schmidt, Rebecca Mccrery, John M. Basgen 
Volume 57, Issue 6, Pages (June 2000)
Joachim Böhler, M.D., Johannes Donauer, Frieder Keller 
Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study1  Robert N. Foley, Charles A. Herzog, Allan J.
Volume 69, Issue 4, Pages (February 2006)
Volume 70, Issue 10, Pages (November 2006)
Volume 63, Issue 2, Pages (February 2003)
Volume 58, Issue 2, Pages (August 2000)
Volume 53, Issue 5, Pages (May 1998)
Volume 80, Issue 10, Pages (November 2011)
Confounding factors in the assessment of delivered hemodialysis dose
Volume 73, Issue 6, Pages (March 2008)
Volume 75, Issue 9, Pages (May 2009)
Glomerular filtration rate via plasma iohexol disappearance: Pilot study for chronic kidney disease in children  G.J. Schwartz, S. Furth, S.R. Cole, B.
Rebound kinetics of β2-microglobulin after hemodialysis
Taqumpay Esmiraldo Tigcal Sacamay, W. Kline Bolton 
Volume 57, Issue 4, Pages (April 2000)
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Volume 56, Issue 3, Pages (September 1999)
George D. Dickinson, Ian Parker  Biophysical Journal 
Presentation transcript:

Volume 67, Issue 2, Pages 721-731 (February 2005) Radionuclide method for evaluating the performance of hemodialysis in vivo  Geoffrey R. Bihl, Nicholas J. Bird, Christina Peters, John R. Bradley, A. Michael Peters  Kidney International  Volume 67, Issue 2, Pages 721-731 (February 2005) DOI: 10.1111/j.1523-1755.2005.67133.x Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 1 Plasma technetium-99m-diethyltriaminepentaacetic acid (Tc-99m-DTPA) concentration recorded continuously for 4 hours after the onset of dialysis in two patients. One (VDTPA= 15.7) was dialyzed with A-18 (upper profile, t1/2 113 minutes from 60 minutes) and the other (VDTPA= 18.8) with F-8 (lower profile, t1/2 130 minutes from 60 minutes). In both patients, the radiotracer was administered intravenously 90 minutes before onset of dialysis and in both, the clearance profile approached a single exponential over the first 60 minutes after which it clearly remained monoexponential until the termination of dialysis. Kidney International 2005 67, 721-731DOI: (10.1111/j.1523-1755.2005.67133.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 2 Relation between the rate constant of technetium-99m-diethyltriaminepentaacetic acid (Tc-99m-DTPA) disappearance from blood, α, and predialysis volume of distribution of (VDTPA). An exponential fit has been used as α is asymptotic to the x axis. The inset shows the similar relation between α and body surface area. Kidney International 2005 67, 721-731DOI: (10.1111/j.1523-1755.2005.67133.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 3 Relation between technetium-99m-diethyltriaminepentaacetic acid (Tc-99m-DTPA) and urea clearances. (A) Tc-99m-DTPA clearance is expressed as plasma clearance (•) and as blood clearance [i.e., plasma clearance divided by (1 – hematocrit)] (○). (B) The corresponding decreases in urea and Tc-99m-DTPA concentrations between the start and end of dialysis. The urea clearance (A) is based on a total body water of 2.5 × VDTPA. Regression equations are shown. Correlation coefficients were lower when urea clearance was based on body surface area with respective values of 0.64 (P < 0.02) and 0.13 (P > 0.05) for bloodKDTPA and plasmaKDTPA, respectively. The concentration ratios in b) have been expressed as the natural logarithms divided by dialysis duration to make them comparable to urea and DTPA clearances, the calculations of which are also based on log transformed concentration ratios and dialysis duration. Regression lines are shown (A) and line of identity (B). Kidney International 2005 67, 721-731DOI: (10.1111/j.1523-1755.2005.67133.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 4 Relation between the volumes of distribution of technetium-99m-diethyltriaminepentaacetic acid (Tc-99m-DTPA) [measured before onset of dialysis (VDTPA)] and chromium-51 ethylenediaminetetraacetic acid (Cr-51-EDTA) [measured after termination of dialysis (VEDTA)]. The continuous line is identity. Kidney International 2005 67, 721-731DOI: (10.1111/j.1523-1755.2005.67133.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 5 Relation between extraction fraction of technetium-99m-diethyltriaminepentaacetic acid (Tc-99m-DTPA) measured (1) from blood samples taken simultaneously from dialyzer inlet and outlet lines (E) and (2) as the quotient, bloodKDTPA and Qb. As a result of changes made in Qb and Qd during dialysis, there was a total of 27 corresponding measurements. The continuous line is identity. Kidney International 2005 67, 721-731DOI: (10.1111/j.1523-1755.2005.67133.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 6 Relations between Qb (A and B) and Qd (C and D) and technetium-99m-diethyltriaminepentaacetic acid (Tc-99m-DTPA) blood clearance (bloodKDTPA) shown for individual patients. In (A and C) bloodKDTPA was calculated by dividing (αcorr.VDTPA) by (1 – hematocrit) while in (B and D) it was calculated as the product of E and Qb. The bold squares are the mean values at particular levels of Qb (180 to 200mL/min and 270 to 350mL/min) (A and B) and Qd (300mL/min, 500mL/min, and 800mL/min) (C and D) and the error bars represent SEM. Kidney International 2005 67, 721-731DOI: (10.1111/j.1523-1755.2005.67133.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 7 Relation between technetium-99m-diethyltriaminepentaacetic acid (Tc-99m-DTPA) blood clearances (bloodKDTPA), respectively, calculated (1) by dividing (αcorr.VDTPA) by (1 – hematocrit) and (2) as the product of E and Qb. The continuous line is identity. Kidney International 2005 67, 721-731DOI: (10.1111/j.1523-1755.2005.67133.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 8 Relation between plasma technetium-99m-diethyltriaminepentaacetic acid (Tc-99m-DTPA) clearance (plasmaKDTPA) and dialyzer plasma flow [calculated as the product of Qb and (1 – hematocrit)]. Left panel, plasmaKDTPA has been calculated as the product of E and Qb (1 – hematocrit). Right panel, plasmaKDTPA is the product of αcorr and VDTPA. The continuous line in the left panel is the regression line. Kidney International 2005 67, 721-731DOI: (10.1111/j.1523-1755.2005.67133.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 9 Compartmental model depicting the distributions of technetium-99m-diethyltriaminepentaacetic acid (Tc-99m-DTPA) and chromium-51-ethylenediaminetetraacetic acie (Cr-51-EDTA). Kidney International 2005 67, 721-731DOI: (10.1111/j.1523-1755.2005.67133.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 10 Compartmental time-concentration curves predicted by the model in Figure 9 following injection of technetium-99m-diethyltriaminepentaacetic acid (Tc-99m-DTPA) into compartment 1. In the absence of any filtration function, the concentrations in the two compartments are predicted to equalize before dialysis is started. After dialysis is started, the concentration in compartment 2 (fine line) is predicted to exceed that in compartment 1 (bold line) while both fall exponentially with the same rate constant. After dialysis is stopped, the concentrations equalize again, a process that leads to a “rebound” (i.e., increase) in the concentration in compartment 1. Kidney International 2005 67, 721-731DOI: (10.1111/j.1523-1755.2005.67133.x) Copyright © 2005 International Society of Nephrology Terms and Conditions

Figure 11 Model of dialysis to predict changes in solute clearance as a result of changes in flow rates of blood and dialysate. Kidney International 2005 67, 721-731DOI: (10.1111/j.1523-1755.2005.67133.x) Copyright © 2005 International Society of Nephrology Terms and Conditions